28068-16-8 (丁酸,2-甲基-(2R,3S,6S,7R,8R)-3-[[3-(甲酰基氨基)-2-羟基苯甲酰基]氨基]-8-己基-2,6-二甲基-4,9-二氧代-1,5-二氧代-7-基酯,Butanoic acid,2-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylester)

CAS号:
28068-16-8
中文名称:
丁酸,2-甲基-(2R,3S,6S,7R,8R)-3-[[3-(甲酰基氨基)-2-羟基苯甲酰基]氨基]-8-己基-2,6-二甲基-4,9-二氧代-1,5-二氧代-7-基酯
英文名称:
Butanoic acid,2-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylester
分子式:
C28H40N2O9
分子量:
548.625208854675

丁酸,2-甲基-(2R,3S,6S,7R,8R)-3-[[3-(甲酰基氨基)-2-羟基苯甲酰基]氨基]-8-己基-2,6-二甲基-4,9-二氧代-1,5-二氧代-7-基酯(28068-16-8)名称与标识符

名称

英文别名:
Butanoic acid,2-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylester;Butanoic acid,2-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxo;1,5-Dioxonane, butanoic acid deriv.;Antimycin A1a;Butyricacid, 2-methyl-, 8-ester with3-formamido-N-(7-hexyl-8-hydroxy-4,9-dimethyl-2,6-dioxo-1,5-dioxonan-3-yl)salicylamide(8CI);Salicylamide,3-formamido-N-(7-hexyl-8-hydroxy-4,9-dimethyl-2,6-dioxo-1,5-dioxonan-3-yl)-,8-(2-methylbutyrate) (8CI);ANJ;Salicylamide, 3-formamido-N-(7-hexyl-8-hydroxy-4,9-dimethyl-2,6-dioxo-1,5-dioxonan-3-yl)-, 8-(2-methylbutyrate);(2r,3s,6s,7r,8r)-3-{[3-(Formylamino)-2-Hydroxybenzoyl]amino}-8-Hexyl-2,6-Dimethyl-4,9-Dioxo-1,5-Dioxonan-7-Yl (2s)-2-Methylbutanoate;Butyric acid, 2-methyl-, 8-ester with 3-formamido-N-(7-hexyl-8-hydroxy-4,9-dimethyl-2,6-dioxo-1,5-dioxonan-3-yl)salicylamide;3CZ99O7K7I;ANTIMYCIN A1A(S);BUTANOIC ACID, 2-METHYL-, (2R,3S,6S,7R,8R)-3-((3-(FORMYLAMINO)-2-HYDROXYBENZOYL)AMINO)-8-HEXYL-2,6-DIMETHYL-4,9-DIOXO-1,5-DIOXONAN-7-YL ESTER, (2S)-;UNII-3CZ99O7K7I;BUTANOIC ACID, 2-METHYL-, 3-((3-(FORMYLAMINO)-2- HYDROXYBENZOYL)AMINO)-8-HEXYL-2,6-DIMETHYL-4,9-DIOXO-1,5- DIOXONAN-7-YL ESTER, (2R-(2R*,3S*,6S*,7R*,8R*))-;Q27257047;Butanoic acid, 2-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, (2R-(2R*,3S*,6S*,7R*,8R*))-;28068-16-8;(2R,3S,6S,7R,8R)-3-({[3-(formylamino)-2-hydroxyphenyl]carbonyl}amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl (2S)-2-methylbutanoate (non-preferred name);

标识符

InChIKey:
UPHOMQADKXDOFD-UKHQZXFMSA-N
Inchi:
1S/C28H40N2O9/c1-6-8-9-10-12-20-24(39-26(34)16(3)7-2)18(5)38-28(36)22(17(4)37-27(20)35)30-25(33)19-13-11-14-21(23(19)32)29-15-31/h11,13-18,20,22,24,32H,6-10,12H2,1-5H3,(H,29,31)(H,30,33)/t16-,17+,18-,20+,22-,24-/m0/s1
SMILES:
O(C([C@@H](C)CC)=O)[C@H]1[C@H](C)OC([C@H]([C@@H](C)OC([C@@H]1CCCCCC)=O)NC(C1C=CC=C(C=1O)NC=O)=O)=O

丁酸,2-甲基-(2R,3S,6S,7R,8R)-3-[[3-(甲酰基氨基)-2-羟基苯甲酰基]氨基]-8-己基-2,6-二甲基-4,9-二氧代-1,5-二氧代-7-基酯(28068-16-8)物化性质

计算特性

  • 精确分子量 : 548.27338086g/mol
  • 氢键供体数量 : 3
  • 氢键受体数量 : 9
  • 可旋转化学键数量 : 12
  • 同位素质量 : 548.27338086g/mol
  • 重原子数量 : 39
  • 复杂度 : 851
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 6
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 5.5
  • 拓扑分子极性表面积 : 157Ų

丁酸,2-甲基-(2R,3S,6S,7R,8R)-3-[[3-(甲酰基氨基)-2-羟基苯甲酰基]氨基]-8-己基-2,6-二甲基-4,9-二氧代-1,5-二氧代-7-基酯(28068-16-8)相关文献